ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,437.47
-1.06%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) 뉴스

INAB IN8bio Inc

1.04
0.00 (0.00%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
IN8bio Inc INAB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 1.04 13:00:11
개장가 저가 고가 종가 전일 종가
1.03 0.99 1.03 1.04 1.04
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202421:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
17/04/202405:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
10/04/202405:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
15/03/202405:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
06/03/202406:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
26/02/202422:00BWIN8bio to Present at Upcoming Investor Conferences
14/02/202422:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
09/02/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
19/01/202406:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/01/202407:16EDGAR2Form S-3 - Registration statement under Securities Act of..
04/01/202422:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
16/12/202306:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202320:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:15EDGAR2Form 8-K - Current report
12/12/202306:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
11/12/202323:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
11/12/202322:56EDGAR2Form 8-K - Current report
09/12/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202306:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/12/202306:15EDGAR2Form 8-K - Current report
07/12/202322:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
05/12/202322:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
20/11/202323:04EDGAR2Form 8-K - Current report
20/11/202321:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10/11/202321:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
10/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:03EDGAR2Form 8-K - Current report
10/11/202306:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..
06/11/202322:00GLOBEIN8bio Presents Biologic Correlative Data from the INB-200..
04/11/202301:00GLOBEIN8bio Presents Positive Data Update from Induced..
02/11/202322:17GLOBEIN8bio to Present New Positive Data from Phase 1 Trial of..
01/11/202321:00GLOBEIN8bio to Participate at the 2023 Truist Securities..
12/10/202321:09EDGAR2Form 8-K - Current report
12/10/202321:00GLOBEIN8bio Completes Dose Escalation in Phase 1 Trial of..
29/09/202321:00GLOBEIN8bio Announces Presentations at the Society for Immunology..

최근 히스토리

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유